Falls Church, VA, United States of America

Julia Tait Lathrop



 

Average Co-Inventor Count = 3.2

ph-index = 2

Forward Citations = 79(Granted Patents)


Company Filing History:


Years Active: 2007-2017

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Julia Tait Lathrop: Innovator in Prion Protein Research

Introduction

Julia Tait Lathrop is a notable inventor based in Falls Church, VA (US). She has made significant contributions to the field of prion protein research, holding a total of five patents. Her work focuses on developing ligands that can detect and remove prion proteins, which are associated with various neurodegenerative diseases.

Latest Patents

One of her latest patents involves prion protein ligands and methods of use. These ligands are designed to bind to prion proteins, enabling their detection or removal from samples, such as biological fluids or environmental samples. The ligands can bind to multiple forms of prion protein, including cellular prion protein (PrPc), infectious prion protein (PrPsc), and recombinant prion protein (PrPr). Notably, these ligands can bind prions from various species, including humans and hamsters. Additionally, her patent provides a method for treating or slowing the development of prion-associated pathologies in subjects.

Career Highlights

Julia has worked with esteemed institutions such as North Carolina State University and Pathogen Removal and Diagnostic Technologies Inc. Her research has been pivotal in advancing the understanding of prion diseases and developing potential therapeutic approaches.

Collaborations

Some of her notable coworkers include David John Hammond and Larisa Cervenakova. Their collaborative efforts have contributed to the innovative research in prion protein detection and treatment.

Conclusion

Julia Tait Lathrop's work in prion protein research exemplifies her dedication to innovation and scientific advancement. Her patents and collaborations highlight her significant impact in the field, paving the way for future developments in prion-related therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…